These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related]
25. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents]. Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791 [TBL] [Abstract][Full Text] [Related]
26. Prehospital use of intravenous diltiazem (cardizem Lyo-Ject) in the treatment of rapid atrial fibrillation. Abarbanell NR; Marcotte MA Am J Emerg Med; 1997 Oct; 15(6):618-9. PubMed ID: 9337374 [No Abstract] [Full Text] [Related]
27. [Industry-promoted research and the significance principle]. Klin Monbl Augenheilkd; 2001 May; 218(5):A90-1. PubMed ID: 11417352 [No Abstract] [Full Text] [Related]
28. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Thompson AE; Shea B; Welch V; Fenlon D; Pope JE Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437 [TBL] [Abstract][Full Text] [Related]
29. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial]. Martsevich SIu; Sementsov DP; Kutishenko NP; Alimova EV Ter Arkh; 2001; 73(9):42-6. PubMed ID: 11642080 [TBL] [Abstract][Full Text] [Related]
30. Conflict of interest in the debate over calcium-channel antagonists. Strandgaard S N Engl J Med; 1998 Jun; 338(23):1697-8. PubMed ID: 9616065 [No Abstract] [Full Text] [Related]
31. [Independent research should be supported]. Als-Nielsen B; Gluud C; Gluud LL Ugeskr Laeger; 2003 Oct; 165(44):4237; author reply 4237-8. PubMed ID: 14621563 [No Abstract] [Full Text] [Related]
32. Break-through for calcium antagonists in the treatment of hypertension based on the Syst-Eur results. Hansson L; Hedner T; Jern S Blood Press; 1998 Jan; 7(1):3-4. PubMed ID: 9551870 [No Abstract] [Full Text] [Related]
33. Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy. Elsheikh BH; Bollman E; Peruggia M; King W; Galloway G; Kissel JT Neurology; 2007 Apr; 68(17):1428-9. PubMed ID: 17452589 [No Abstract] [Full Text] [Related]
34. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study]. Schillaci G; Verdecchia P Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297 [No Abstract] [Full Text] [Related]
35. [No bluff to be discovered in clinical trials]. Berglund T Lakartidningen; 2009 Mar 25-31; 106(13):952-3. PubMed ID: 19441200 [No Abstract] [Full Text] [Related]
36. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Held PH; Yusuf S Coron Artery Dis; 1994 Jan; 5(1):21-6. PubMed ID: 8136928 [No Abstract] [Full Text] [Related]
37. Industry collaboration and randomized clinical trial design and outcomes. Roper N; Zhang N; Korenstein D JAMA Intern Med; 2014 Oct; 174(10):1695-6. PubMed ID: 25156272 [No Abstract] [Full Text] [Related]
38. Commentary: biostatistics, biological mechanisms and Bayes: lessons from the magnesium trials. Woods KL Int J Epidemiol; 2002 Feb; 31(1):105-6. PubMed ID: 11914303 [No Abstract] [Full Text] [Related]
39. "Cardioprotection"--not all calcium antagonists are created equal. Messerli FH Cor Vasa; 1993; 35(6):287-8. PubMed ID: 8149766 [No Abstract] [Full Text] [Related]
40. [Role of diltiazem in the post-infarct period]. Milazzotto F; Tubaro M G Ital Cardiol; 1987 Feb; 17(2):164-71. PubMed ID: 3301501 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]